What Is Lyophilization?

Lyophilization (freeze-drying) is the standard method for preserving research peptides in stable, long-term storage form. The process involves:

  1. Freezing — the peptide solution is frozen to −40°C or below
  2. Primary drying — sublimation removes bulk water under vacuum
  3. Secondary drying — residual bound water is removed at slightly elevated temperature under vacuum

The result is a dry, porous cake or powder with typically <1% residual moisture. In this form, most research peptides remain stable at −20°C for 24 months or longer when stored with a desiccant and protected from light.

Rainbow Peptide supplies all products as lyophilized powder in glass vials, sealed under nitrogen or vacuum with rubber stoppers to prevent moisture ingress.

Choosing a Reconstitution Solvent

Bacteriostatic Water (Most Common)

Bacteriostatic water for injection (BWFI) contains 0.9% benzyl alcohol USP in sterile water. The benzyl alcohol inhibits bacterial contamination, allowing multi-draw use from the same vial for up to 28 days at 4°C. This is the preferred solvent for most research peptide applications and is included with peptide orders from Rainbow Peptide.

Sterile 0.9% Saline

Sterile physiological saline (NaCl 0.9%) is isotonic and suitable for single-use reconstitution. It provides no bacterial growth inhibition, so multi-dose use requires strict aseptic technique. Some research protocols specify saline to avoid any potential benzyl alcohol effects on sensitive assay systems.

Sterile Water for Injection (WFI)

Pure sterile water with no additives. Appropriate for immediate single-use experiments and in vitro cell culture applications where osmolality control is managed by the culture medium. Not recommended for multi-draw in vivo research vials.

Acetic Acid (0.1–1%)

For peptides with poor aqueous solubility (often hydrophobic sequences or peptides with high arginine content), dilute acetic acid can improve dissolution. Typically 10–30 µL of 1% acetic acid is added first to displace the lyophilized cake, followed by the remaining volume of bacteriostatic water.

Aseptic Reconstitution Technique

For in vivo animal research, aseptic technique is essential to prevent vial contamination. Standard procedure:

  1. Work area: Wipe surface with 70% isopropanol. Use a laminar flow hood if available for sensitive research.
  2. Prepare materials: Bacteriostatic water vial, sterile syringe (1–3 mL), needle (21–25 G), peptide vial, alcohol swabs.
  3. Wipe both vial tops with alcohol swabs. Allow to dry for 10–15 seconds.
  4. Draw bacteriostatic water: Withdraw the calculated volume into the syringe.
  5. Inject slowly: Insert needle through the rubber stopper of the peptide vial. Direct the stream of water against the glass wall, not directly onto the lyophilized cake. This prevents denaturation from mechanical shear.
  6. Do not shake: Gently swirl or roll the vial between your palms until fully dissolved. Shaking can cause peptide aggregation or foaming.
  7. Inspect: Solution should be clear and colourless (some peptides produce a slightly yellow tint which is normal). Visible particles indicate incomplete dissolution or contamination — do not use.

Concentration Calculations

The key formula: Concentration (mg/mL) = Mass (mg) ÷ Volume (mL)

Common Reconstitution Examples

Vial Size Water Added Concentration U-100 Syringe (1 mg dose)
5 mg 1 mL 5 mg/mL (5,000 µg/mL) 20 units
5 mg 2 mL 2.5 mg/mL (2,500 µg/mL) 40 units
5 mg 5 mL 1 mg/mL (1,000 µg/mL) 100 units (full syringe)
10 mg 2 mL 5 mg/mL (5,000 µg/mL) 20 units

Note on U-100 insulin syringes: A U-100 insulin syringe holds 1 mL and is marked in 100 units. 1 unit = 0.01 mL. This is a common and convenient measuring tool in peptide research because of its fine graduation. The calculation: units to draw = (dose in mg ÷ concentration in mg/mL) × 100

Use the Rainbow Peptide Reconstitution Calculator to automate these calculations for any vial size and dose.

Handling Poorly Soluble Peptides

Most research peptides dissolve readily in bacteriostatic water. Some with hydrophobic residues or specific charge profiles require additional steps:

  • Warming: Gently warm the vial in your palm or a 37°C water bath (do not exceed 40°C) — warmth improves solubility without degrading most peptides.
  • Sonication: Brief bath sonication (30–60 seconds) can break up aggregates in research-grade equipment.
  • 1% acetic acid pre-treatment: Add 10–20 µL of 1% acetic acid first, gently swirl, then add remaining bacteriostatic water. Useful for cationic peptides (high lysine/arginine content).
  • DMSO co-solvent: For very hydrophobic peptides in cell culture applications, prepare a concentrated stock in DMSO (<0.1% final DMSO concentration in culture medium to avoid cytotoxicity).

Storage Conditions & Stability

Form Condition Expected Stability
Lyophilized powder −20°C, desiccated, dark 24+ months
Reconstituted, bacteriostatic water 4°C (refrigerator) 14–28 days
Reconstituted, frozen −20°C (single aliquots) 3–6 months
Reconstituted, bench Room temperature (>22°C) <24 hours

Freeze-thaw cycles: Each cycle can cause peptide degradation through ice crystal formation and mechanical stress. Best practice: once reconstituted, aliquot into single-use doses (e.g., in 0.5 mL microtubes) and freeze. Thaw only what is needed for each session.

Light sensitivity: Several research peptides (particularly those with aromatic residues like Trp, Tyr) are photosensitive. Store reconstituted solutions in amber vials or wrapped in foil if working at room temperature.

Using the Rainbow Peptide Calculator

The Rainbow Peptide Reconstitution & Dosage Calculator is a free research tool that handles all the math:

  • Enter your vial size (mg) and water volume (mL) → get mg/mL concentration
  • Enter your target dose (µg or mg) → get the exact volume and U-100 units to draw
  • Quick-fill presets for BPC-157, TB-500, GHK-Cu, Ipamorelin, and more

The calculator also shows concentration per unit on a U-100 syringe for any reconstitution configuration — the most practical output for subcutaneous and intraperitoneal research protocols.